Effect of phosphodiesterase inhibitors on renal functions and oxidant/antioxidant parameters in streptozocin-induced diabetic rats

Arch Physiol Biochem. 2018 Dec;124(5):424-429. doi: 10.1080/13813455.2017.1419267. Epub 2017 Dec 22.

Abstract

The goal of this study was to investigate the effect of different phosphodiesterase inhibitors (PDEIs), on renal oxidant/antioxidant balance in diabetic rats. Our study was conducted on 125 rats, diabetes was induced in 100 rats by a single administration of streptozocin (STZ). Diabetic rats were divided into four equal groups. The first group was assigned as diabetic control, the remaining three groups were treated with pentoxifylline, sildenafil and milrinone via drinking water for 15 successive days, another group of 25 normal rats was assigned as non-diabetic control. Significant increase in plasma levels of glucose, urea, creatinine, malondialdehyde (MDA), and nitric oxide (NO) with a concomitant decrease in the levels of insulin, reduced glutathione (GSH), glutathione peroxidase (Gpx), superoxide dismutase (SOD), catalase (CAT), and total antioxidant capacity (TAC) were observed in diabetic rats. These alterations were reverted back to near normal level after treatment with PDEIs. Our data seem to suggest a potential role of PDEIs in maintaining health in diabetes by reducing the progression of diabetic nephropathy.

Keywords: Diabetes; milrinone; oxidative stress; pentoxifylline; sildenafil.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antioxidants / adverse effects
  • Antioxidants / therapeutic use*
  • Diabetes Mellitus, Experimental / complications
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / physiopathology
  • Diabetic Nephropathies / prevention & control*
  • Hyperglycemia / prevention & control
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use
  • Insulin Resistance
  • Kidney / drug effects*
  • Kidney / physiopathology
  • Lipid Peroxidation / drug effects
  • Male
  • Milrinone / adverse effects
  • Milrinone / therapeutic use
  • Oxidative Stress / drug effects*
  • Oxidoreductases / blood
  • Pentoxifylline / adverse effects
  • Pentoxifylline / therapeutic use
  • Phosphodiesterase 3 Inhibitors / adverse effects
  • Phosphodiesterase 3 Inhibitors / therapeutic use
  • Phosphodiesterase 5 Inhibitors / adverse effects
  • Phosphodiesterase 5 Inhibitors / therapeutic use
  • Phosphodiesterase Inhibitors / adverse effects
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Random Allocation
  • Rats, Sprague-Dawley
  • Renal Insufficiency / complications
  • Renal Insufficiency / prevention & control*
  • Sildenafil Citrate / adverse effects
  • Sildenafil Citrate / therapeutic use

Substances

  • Antioxidants
  • Hypoglycemic Agents
  • Phosphodiesterase 3 Inhibitors
  • Phosphodiesterase 5 Inhibitors
  • Phosphodiesterase Inhibitors
  • Sildenafil Citrate
  • Oxidoreductases
  • Milrinone
  • Pentoxifylline